http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872069-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9613789c35ff3b409910828d6498cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be67a8a80230cdd4b76514f81e83a79c |
publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102872069-B |
titleOfInvention | Application of Houttuynoid C to preparing drugs for treating liver cancer |
abstract | The invention discloses application of Houttuynoid C to preparing drugs for treating liver cancer, belonging to the technical field of new uses of the drugs. According to the invention, found by in vitro methyl thiazolyl tetrazolium (MTT) antineoplastic activity evaluation, Houttuynoid C also has remarkable inhibition effect on the growth of human hepatoma cell lines HepG2, MHCC-LM3, Bel-7402 andHuH-7. Therefore, Houttuynoid C can be used for preparing the drugs for resisting the liver cancer and has good development and application prospects. The application of Houttuynoid C to preparing the drugs for treating the liver cancer, disclosed by the invention, is firstly published; the framework type is brand new; and the activity of inhibiting the liver cancer cells is unexpectedly strong. |
priorityDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.